HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lisa Licitra Selected Research

Salivary Gland Neoplasms (Salivary Gland Cancer)

12/2021Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial.
10/2019Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract.
5/2016Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers.
6/2014Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy.
1/2013Salivary gland cancer: an update on present and emerging therapies.
9/2012Management of salivary gland tumors.
6/2006Systemic therapy in the palliative management of advanced salivary gland cancers.
5/2004Head and neck tumors other than squamous cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lisa Licitra Research Topics

Disease

62Neoplasms (Cancer)
02/2022 - 01/2003
54Squamous Cell Carcinoma of Head and Neck
01/2022 - 11/2006
38Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 08/2002
10Carcinoma (Carcinomatosis)
12/2021 - 11/2009
9Fatigue
12/2021 - 10/2013
9Squamous Cell Neoplasms (Squamous Cell Cancer)
12/2019 - 01/2003
8Salivary Gland Neoplasms (Salivary Gland Cancer)
12/2021 - 05/2004
8Neoplasm Metastasis (Metastasis)
06/2021 - 02/2003
8Basal Cell Carcinoma (Rodent Ulcer)
01/2021 - 01/2015
8Disease Progression
01/2020 - 11/2016
7Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2022 - 06/2007
7Oropharyngeal Neoplasms
10/2021 - 12/2006
7Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
08/2021 - 01/2004
6Nasopharyngeal Carcinoma
12/2021 - 01/2004
6Thyroid Neoplasms (Thyroid Cancer)
01/2021 - 07/2008
5Stomatitis
10/2019 - 09/2014
4Adenocarcinoma
01/2020 - 06/2003
4Adenoid Cystic Carcinoma (Cylindroma)
10/2019 - 10/2005
4Pain (Aches)
01/2017 - 10/2015
4Mucositis
12/2016 - 02/2012
3Melanoma (Melanoma, Malignant)
11/2021 - 10/2017
3Anaplastic Thyroid Carcinoma
01/2021 - 02/2014
3Diarrhea
10/2019 - 10/2013
3Exanthema (Rash)
10/2019 - 10/2013
3Deglutition Disorders (Dysphagia)
01/2019 - 11/2015
3Neutropenia
01/2017 - 02/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 04/2013
2Hemorrhage
01/2021 - 04/2009
2Hypoxia (Hypoxemia)
01/2020 - 04/2015
2Pneumonia (Pneumonitis)
12/2019 - 06/2014
2Nausea
10/2019 - 10/2013
2Weight Loss (Weight Reduction)
01/2019 - 01/2017
2medullary Thyroid cancer
01/2018 - 10/2013
2Colorectal Neoplasms (Colorectal Cancer)
04/2013 - 10/2006
2Genetic Predisposition to Disease (Genetic Predisposition)
04/2006 - 07/2003
2Avitaminosis (Vitamin Deficiency)
07/2003 - 01/2002
1Flushing
12/2021
1Supraventricular Tachycardia
12/2021
1Liver Neoplasms (Liver Cancer)
06/2021
1Wounds and Injuries (Trauma)
01/2021
1Bone Fractures (Bone Fracture)
01/2021

Drug/Important Bio-Agent (IBA)

27PlatinumIBA
01/2022 - 10/2005
20Cetuximab (Erbitux)FDA Link
01/2020 - 10/2005
13NivolumabIBA
01/2022 - 11/2016
13Cisplatin (Platino)FDA LinkGeneric
10/2021 - 07/2002
11Biological ProductsIBA
01/2020 - 06/2006
9Biomarkers (Surrogate Marker)IBA
04/2020 - 11/2006
7Pharmaceutical PreparationsIBA
12/2021 - 10/2014
7Immune Checkpoint InhibitorsIBA
11/2021 - 10/2017
7DNA (Deoxyribonucleic Acid)IBA
01/2021 - 11/2006
7Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 01/2004
7HhAntag691IBA
12/2018 - 01/2015
6Methotrexate (Mexate)FDA LinkGeneric
12/2019 - 04/2009
5Androgen Receptors (Androgen Receptor)IBA
12/2021 - 05/2004
5pembrolizumabIBA
01/2021 - 01/2019
4AndrogensIBA
12/2021 - 06/2014
4ErbB Receptors (EGF Receptor)IBA
01/2021 - 04/2013
4MicroRNAs (MicroRNA)IBA
01/2020 - 01/2017
4Docetaxel (Taxotere)FDA Link
12/2019 - 11/2016
4Carboplatin (JM8)FDA LinkGeneric
01/2019 - 02/2014
4Paclitaxel (Taxol)FDA LinkGeneric
01/2018 - 02/2014
3cemiplimabIBA
05/2022 - 01/2021
3LigandsIBA
10/2021 - 12/2014
3lenvatinibIBA
01/2021 - 04/2018
3B7-H1 AntigenIBA
01/2021 - 04/2018
3Axitinib (AG 013736)IBA
10/2019 - 01/2014
3Monoclonal AntibodiesIBA
01/2018 - 07/2013
3CarcinogensIBA
04/2006 - 01/2002
2Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 01/2016
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2021 - 07/2008
2Proteins (Proteins, Gene)FDA Link
01/2020 - 04/2013
2Long Noncoding RNAIBA
01/2020 - 01/2017
2AfatinibIBA
10/2019 - 01/2018
2IodineIBA
09/2018 - 04/2015
2avelumabIBA
08/2018 - 10/2017
2Phosphotransferases (Kinase)IBA
04/2018 - 04/2015
2Panitumumab (Vectibix)FDA Link
01/2018 - 07/2013
2NVP-BKM120IBA
01/2018 - 01/2017
2fosbretabulin (combretastatin A4)IBA
10/2014 - 02/2014
2Tyrosine Kinase InhibitorsIBA
12/2013 - 10/2013
2Gefitinib (Iressa)FDA Link
11/2012 - 04/2009
2Cyclin-Dependent Kinase Inhibitor p16IBA
10/2006 - 06/2003
1Abiraterone AcetateIBA
12/2021
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2021
1monalizumabIBA
10/2021
1HLA Antigens (Human Leukocyte Antigens)IBA
10/2021
1tipifarnib (R115777)IBA
10/2021

Therapy/Procedure

50Drug Therapy (Chemotherapy)
01/2022 - 07/2002
49Therapeutics
01/2022 - 06/2006
33Radiotherapy
11/2021 - 08/2002
10Chemoradiotherapy
01/2020 - 11/2009
9Immunotherapy
12/2021 - 01/2016
8Induction Chemotherapy
02/2022 - 02/2014
7Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
02/2020 - 05/2004
3Aftercare (After-Treatment)
01/2021 - 12/2016
2Time-to-Treatment
05/2021 - 01/2016
2Metastasectomy
01/2017 - 10/2005
1Castration
12/2021
1Heavy Ion Radiotherapy
11/2021
1Radiofrequency Ablation
06/2021